Suppr超能文献

血小板浓缩液储存期间,合成或天然存在的血小板衍生微粒表面脱落的HLA抗原。

HLA Antigens Shed from the Surface of Synthetic or Naturally Occurred Platelet-Derived Microparticles During Storage of Platelet Concentrate.

作者信息

Yari Fatemeh, Ahmadzadeh Noushin, Azadpour Shima, Vaeli Shahram

机构信息

Research Center, Iranian Blood Transfusion Organization, 14665-1157 Tehran, Iran.

出版信息

Indian J Hematol Blood Transfus. 2012 Sep;28(3):152-6. doi: 10.1007/s12288-011-0120-0. Epub 2011 Oct 20.

Abstract

The demand for standard platelet concentrates (PCs) has continued to increase in the recent years. Infusible platelet membranes (IPM) prepared from new or outdated human platelets have been developed as an alternative to standard PCs, with the additional advantage of long shelf life and increased viral safety. Reduction of HLA antigens on the IPM has been assigned as one of the probable advantages of this product. In re-examining this issue, we studied the existence of HLA class I on the surface of IPM microparticles. In comparison we also surveyed HLA expression on the surface of the naturally occurred platelet-derived microparticles (nPMPs) during 7 days storage. Intended for producing IPM, PCs obtained from Iranian blood transfusion organization were lysed; virally inactivated with wet heat in the presence of a heat stabilizer and then sonicated. IPMs were separated using centrifugation and liquid-stored in 4°C. The expression of HLA class I antigens was surveyed using flow cytometry technique. HLA molecules were present on the microparticles. Shedding of HLA antigens was demonstrated from the surface of the both liquid-stored IPM and nPMPs during storage. Storage of IPM in 4°C was accompanied with significant reduction of HLA molecules. It seemed that achievement of HLA-free IPM could be impossible unless chloroquine treated platelets were used to prepare these microvesicles.

摘要

近年来,对标准血小板浓缩物(PCs)的需求持续增长。由新鲜或过期人血小板制备的可输注血小板膜(IPM)已被开发出来作为标准PCs的替代品,具有保质期长和病毒安全性提高的额外优势。降低IPM上的HLA抗原被认为是该产品的可能优势之一。在重新审视这个问题时,我们研究了IPM微粒表面是否存在HLA I类分子。作为对比,我们还调查了天然存在的血小板衍生微粒(nPMPs)在储存7天期间表面的HLA表达情况。为了制备IPM,将从伊朗输血组织获得的PCs进行裂解;在热稳定剂存在下用湿热进行病毒灭活,然后进行超声处理。通过离心分离IPM,并在4°C下液体储存。使用流式细胞术技术检测HLA I类抗原的表达。微粒上存在HLA分子。在储存期间,液体储存的IPM和nPMPs表面均出现HLA抗原脱落。将IPM储存在4°C会伴随着HLA分子的显著减少。除非使用经氯喹处理的血小板来制备这些微泡,否则似乎不可能获得无HLA的IPM。

相似文献

2
Glycoproteins of GpIbα and GpIIbIIIa on the Synthetic or Naturally Occurred Platelet-Derived Microparticles.
Indian J Hematol Blood Transfus. 2013 Sep;29(3):134-8. doi: 10.1007/s12288-012-0170-y. Epub 2012 Jul 4.
4
Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets.
Transfusion. 1996 Jun;36(6):536-42. doi: 10.1046/j.1537-2995.1996.36696269513.x.

本文引用的文献

2
Current concepts in platelet transfusion.血小板输注的当前概念。
Asian J Transfus Sci. 2009 Jan;3(1):18-21. doi: 10.4103/0973-6247.45257.
5
Cellular microparticles: new players in the field of vascular disease?细胞微粒:血管疾病领域的新角色?
Eur J Clin Invest. 2004 Jun;34(6):392-401. doi: 10.1111/j.1365-2362.2004.01355.x.
6
Substitutes and alternatives to platelet transfusions in thrombocytopenic patients.
J Thromb Haemost. 2003 Jul;1(7):1637-41. doi: 10.1046/j.1538-7836.2003.00332.x.
8
Novel platelet products, substitutes and alternatives.新型血小板制品、替代品及替代物。
Transfus Clin Biol. 2001 Jun;8(3):267-71. doi: 10.1016/s1246-7820(01)00127-6.
9
Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex.
Am J Clin Pathol. 2001 Jan;115(1):144-7. doi: 10.1309/CCDV-3BEP-XXKP-BKDM.
10
Platelet substitutes and novel platelet products.血小板替代物和新型血小板制品。
Expert Opin Investig Drugs. 2000 Mar;9(3):457-69. doi: 10.1517/13543784.9.3.457.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验